Interactions between non-identical prion proteins

Seminars in Cell and Developmental Biology

Volumn 22, Issue 5, 2011, Pages 437-443

  Gonzalez Nelson, Aaron C ^a   Ross, Eric D ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Amyloid; Prion; Species barrier; Yeast

Indexed keywords

PRION PROTEIN;

AMINO ACID SEQUENCE; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW; SACCHAROMYCES CEREVISIAE; SPECIES DIFFERENCE;

SACCHAROMYCES CEREVISIAE;

EID: 80053569966     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2011.02.022     Document Type: Review

References (79)

1. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216:136-144.
2. Aguzzi A., Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 2004, 116:313-327.
3. Wickner R.B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 1994, 264:566-569.
4. Sondheimer N., Lindquist S. Rnq1: an epigenetic modifier of protein function in yeast. Mol Cell 2000, 5:163-172.
5. Derkatch I.L., Bradley M.E., Hong J.Y., Liebman S.W. Prions affect the appearance of other prions: the story of [PIN(+)]. Cell 2001, 106:171-182.
6. Wickner R.B., Shewmaker F., Kryndushkin D., Edskes H.K. Protein inheritance (prions) based on parallel in-register beta-sheet amyloid structures. Bioessays 2008, 30:955-964.
7. Pierce M.M., Baxa U., Steven A.C., Bax A., Wickner R.B. Is the prion domain of soluble Ure2p unstructured?. Biochemistry 2005, 44:321-328.
8. Serio T.R., Cashikar A.G., Kowal A.S., Sawicki G.J., Moslehi J.J., Serpell L., et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 2000, 289:1317-1321.
9. Wickner R.B., Edskes H.K., Maddelein M.L., Taylor K.L., Moriyama H. Prions of yeast and fungi. Proteins as genetic material. J Biol Chem 1999, 274:555-558.
10. Wickner R.B. A new prion controls fungal cell fusion incompatibility. Proc Natl Acad Sci USA 1997, 94:10012-10014.
11. Eaglestone S.S., Cox B.S., Tuite M.F. Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J 1999, 18:1974-1981.
12. True H.L., Lindquist S.L. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 2000, 407:477-483.
13. Tyedmers J., Madariaga M.L., Lindquist S. Prion switching in response to environmental stress. PLoS Biol 2008, 6:e294.
14. Nakayashiki T., Kurtzman C.P., Edskes H.K., Wickner R.B. Yeast prions [URE3] and [PSI+] are diseases. Proc Natl Acad Sci USA 2005, 102:10575-10580.
15. Cobb N.J., Sonnichsen F.D., McHaourab H., Surewicz W.K. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc Natl Acad Sci USA 2007, 104:18946-18951.
16. Tycko R., Savtchenko R., Ostapchenko V.G., Makarava N., Baskakov I.V. The alpha-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel beta-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry 2010, Epub ahead of print.
17. Govaerts C., Wille H., Prusiner S.B., Cohen F.E. Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci USA 2004, 101:8342-8347.
18. Shewmaker F., Wickner R.B., Tycko R. Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure. Proc Natl Acad Sci USA 2006, 103:19754-19759.
19. Baxa U., Wickner R.B., Steven A.C., Anderson D.E., Marekov L.N., Yau W.-M., et al. Characterization of beta-sheet structure in Ure2p1-89 yeast prion fibrils by solid-state nuclear magnetic resonance. Biochemistry 2007, 46:13149-13162.
20. Wickner R.B., Dyda F., Tycko R. Amyloid of Rnq1p, the basis of the [PIN+] prion, has a parallel in-register beta-sheet structure. Proc Natl Acad Sci USA 2008, 105:2403-2408.
21. Krishnan R., Lindquist S.L. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 2005, 435:765-772.
22. Hilbich C., Kisters-Woike B., Reed J., Masters C.L., Beyreuther K. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J Mol Biol 1991, 218:149-163.
23. Petkova A.T., Ishii Y., Balbach J.J., Antzutkin O.N., Leapman R.D., Delaglio F., et al. A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 2002, 99:16742-16747.
24. Perutz M.F., Johnson T., Suzuki M., Finch J.T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 1994, 91:5355-5358.
25. Nelson R., Sawaya M.R., Balbirnie M., Madsen A.O., Riekel C., Grothe R., et al. Structure of the cross-beta spine of amyloid-like fibrils. Nature 2005, 435:773-778.
26. Paushkin S.V., Kushnirov V.V., Smirnov V.N., Ter-Avanesyan M.D. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 1996, 15:3127-3134.
27. Rikhvanov E.G., Romanova N.V., Chernoff Y.O. Chaperone effects on prion and nonprion aggregates. Prion 2007, 1:217-222.
28. Ness F., Ferreira P., Cox B.S., Tuite M.F. Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol Cell Biol 2002, 22:5593-5605.
29. Wegrzyn R.D., Bapat K., Newnam G.P., Zink A.D., Chernoff Y.O. Mechanism of prion loss after Hsp104 inactivation in yeast. Mol Cell Biol 2001, 21:4656-4669.
30. Romanova N.V., Chernoff Y.O. Hsp104 and prion propagation. Protein Pept Lett 2009, 16:598-605.
31. Pattison I.H. Experiments with scrapie with special reference to the nature of the agent and the pathology of the disease. Slow, Latent and Temperate Virus Infections, NINDB Monograph 2 1965, 249-257. US Government Printing Office, Washington, DC. D.C. Gajdusek, C.J. Gibbs, M.P. Alpers (Eds.).
32. Nakayashiki T., Ebihara K., Bannai H., Nakamura Y. Yeast [PSI+] "prions" that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. Mol Cell 2001, 7:1121-1130.
33. Chen B., Newnam G.P., Chernoff Y.O. Prion species barrier between the closely related yeast proteins is detected despite coaggregation. Proc Natl Acad Sci USA 2007, 104:2791-2796.
34. Chernoff Y.O., Galkin A.P., Lewitin E., Chernova T.A., Newnam G.P., Belenkiy S.M. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein. Mol Microbiol 2000, 35:865-876.
35. Santoso A., Chien P., Osherovich L.Z., Weissman J.S. Molecular basis of a yeast prion species barrier. Cell 2000, 100:277-288.
36. Collinge J., Clarke A.R. A general model of prion strains and their pathogenicity. Science 2007, 318:930-936.
37. Scott M., Foster D., Mirenda C., Serban D., Coufal F., Walchli M., et al. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 1989, 59:847-857.
38. Caughey B., Raymond G.J., Bessen R.A. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem 1998, 273:32230-32235.
39. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998, 4:1157-1165.
40. Tanaka M., Chien P., Naber N., Cooke R., Weissman J.S. Conformational variations in an infectious protein determine prion strain differences. Nature 2004, 428:323-328.
41. Hill A.F., Desbruslais M., Joiner S., Sidle K.C., Gowland I., Collinge J., et al. The same prion strain causes vCJD and BSE. Nature 1997, 389:448-450. 526.
42. Flechsig E., Weissmann C. The role of PrP in health and disease. Curr Mol Med 2004, 4:337-353.
43. Wang F., Wang X., Yuan C.G., Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010, 327:1132-1135.
44. Makarava N., Lee C.I., Ostapchenko V.G., Baskakov I.V. Highly promiscuous nature of prion polymerization. J Biol Chem 2007, 282:36704-36713.
45. King C.Y., Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature 2004, 428:319-323.
46. Bruce KL, Chernoff YO, Sequence specificity and fidelity of prion transmission in yeast. Seminars in Cell and Developmental Biology; this issue.
47. DePace A.H., Santoso A., Hillner P., Weissman J.S. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 1998, 93:1241-1252.
48. Liu J.J., Lindquist S. Oligopeptide-repeat expansions modulate 'protein-only' inheritance in yeast. Nature 1999, 400:573-576.
49. Chien P., Weissman J.S. Conformational diversity in a yeast prion dictates its seeding specificity. Nature 2001, 410:223-227.
50. Chien P., DePace A.H., Collins S.R., Weissman J.S. Generation of prion transmission barriers by mutational control of amyloid conformations. Nature 2003, 424:948-951.
51. Chen B., Bruce K.L., Newnam G.P., Gyoneva S., Romanyuk A.V., Chernoff Y.O. Genetic and epigenetic control of the efficiency and fidelity of cross-species prion transmission. Mol Microbiol 2010, 76:1483-1499.
52. Lopez de la Paz M., Serrano L. Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci USA 2004, 101:87-92.
53. Toombs J.A., McCarty B.R., Ross E.D. Compositional determinants of prion formation in yeast. Mol Cell Biol 2010, 30:319-332.
54. Ross E.D., Toombs J.A. The effects of amino acid composition on yeast prion formation and prion domain interactions. Prion 2010, 4:60-65.
55. Osherovich L.Z., Cox B.S., Tuite M.F., Weissman J.S. Dissection and design of yeast prions. PLoS Biol 2004, 2:E86.
56. Tessier P.M., Lindquist S. Prion recognition elements govern nucleation, strain specificity and species barriers. Nature 2007, 447:556-561.
57. Edskes H.K., McCann L.M., Hebert A.M., Wickner R.B. Prion variants and species barriers among Saccharomyces Ure2 proteins. Genetics 2009, 181:1159-1167.
58. Mukhopadhyay S., Krishnan R., Lemke E.A., Lindquist S., Deniz A.A. A natively unfolded yeast prion monomer adopts an ensemble of collapsed and rapidly fluctuating structures. Proc Natl Acad Sci USA 2007, 104:2649-2654.
59. Tuite M.F., Mundy C.R., Cox B.S. Agents that cause a high frequency of genetic change from [psi+] to [psi-] in Saccharomyces cerevisiae. Genetics 1981, 98:691-711.
60. Ferreira P.C., Ness F., Edwards S.R., Cox B.S., Tuite M.F. The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol Microbiol 2001, 40:1357-1369.
61. Jung G., Masison D.C. Guanidine hydrochloride inhibits Hsp104 activity in vivo: a possible explanation for its effect in curing yeast prions. Curr Microbiol 2001, 43:7-10.
62. Chernoff Y.O., Lindquist S.L., Ono B., Inge-Vechtomov S.G., Liebman S.W. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 1995, 268:880-884.
63. Derkatch I.L., Bradley M.E., Zhou P., Chernoff Y.O., Liebman S.W. Genetic and environmental factors affecting the de novo appearance of the [PSI(+)] prion in Saccharomyces cerevisiae. Genetics 1997, 147:507-519.
64. Derkatch I.L., Bradley M.E., Masse S.V., Zadorsky S.P., Polozkov G.V., Inge-Vechtomov S.G., et al. Dependence and independence of [PSI(+)] and [PIN(+)]: a two-prion system in yeast?. EMBO J 2000, 19:1942-1952.
65. Derkatch I.L., Uptain S.M., Outeiro T.F., Krishnan R., Lindquist S.L., Liebman S.W. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proc Natl Acad Sci USA 2004, 101:12934-12939.
66. Salnikova A.B., Kryndushkin D.S., Smirnov V.N., Kushnirov V.V., Ter-Avanesyan M.D. Nonsense suppression in yeast cells overproducing Sup35 (eRF3) is caused by its non-heritable amyloids. J Biol Chem 2005, 280:8808-8812.
67. Choe Y.J., Ryu Y., Kim H.J., Seok Y.J. Increased [PSI+] appearance by fusion of Rnq1 with the prion domain of Sup35 in Saccharomyces cerevisiae. Eukaryot Cell 2009, 8:968-976.
68. Ganusova E.E., Ozolins L.N., Bhagat S., Newnam G.P., Wegrzyn R.D., Sherman M.Y., et al. Modulation of prion formation, aggregation, and toxicity by the actin cytoskeleton in yeast. Mol Cell Biol 2006, 26:617-629.
69. Bagriantsev S., Liebman S.W. Specificity of prion assembly in vivo: [PSI+] AND [PIN+] form separate structures in yeast. J Biol Chem 2004, 279:51042-51048.
70. Osherovich L.Z., Weissman J.S. Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell 2001, 106:183-194.
71. Bradley M.E., Edskes H.K., Hong J.Y., Wickner R.B., Liebman S.W. Interactions among prions and prion "strains" in yeast. Proc Natl Acad Sci USA 2002, 99(Suppl. 4):16392-16399.
72. Vitrenko Y.A., Pavon M.E., Stone S.I., Liebman S.W. Propagation of the [PIN+] prion by fragments of Rnq1 fused to GFP. Curr Genet 2007, 51:309-319.
73. Kadnar M.L., Articov G., Derkatch I.L. Distinct type of transmission barrier revealed by study of multiple prion determinants of Rnq1. PLoS 2010, 6:e1000824.
74. Bardill J.P., True H.L. Heterologous prion interactions are altered by mutations in the prion protein Rnq1p. J Mol Biol 2009, 388:583-596.
75. Vishveshwara N., Liebman S.W. Heterologous cross-seeding mimics cross-species prion conversion in a yeast model. BMC Biol 2009, 7:26.
76. Ross E.D., Baxa U., Wickner R.B. Scrambled prion domains form prions and amyloid. Mol Cell Biol 2004, 24:7206-7213.
77. Ross C.D., McCarty B.M., Hamilton M., Ben-Hur A., Ross E.D. A promiscuous prion: Efficient induction of [URE3] prion formation by heterologous prion domains. Genetics 2009, 183:929-940.
78. Schwimmer C., Masison D.C. Antagonistic interactions between yeast [PSI(+)] and [URE3] prions and curing of [URE3] by Hsp70 protein chaperone Ssa1p but not by Ssa2p. Mol Cell Biol 2002, 22:3590-3598.
79. Bradley M.E., Liebman S.W. Destabilizing interactions among [PSI(+)] and [PIN(+)] yeast prion variants. Genetics 2003, 165:1675-1685.